In summary, our research uncovered the interesting role of ketamine in TNF-α-induced SIRS, which inhibits necroptosis by affecting RIP1 ubiquitination levels and the formation of necrosomes and reducing the release of inflammatory cytokines. The gene discussed is TNF; the disease is systemic inflammatory response syndrome.